Home » Topics » BioWorld Science

BioWorld Science
RSS

Beijing Gegen Biotechnology, Yicon Medical Science and Technology Co. patent anti-EGFR antibodies

June 8, 2018

FDA grants orphan drug designation to olinciguat for sickle cell disease

June 8, 2018

Guangdong Longchuangji Pharmacy Co. presents Lactobacillus rhamnosus strain

June 8, 2018

FDA and EMA accepts regulatory submissions of talazoparib for review

June 8, 2018

Bristol-Myers Squibb describes integrin alpha-V antagonists

June 8, 2018

RDX-023: A non-bile acid FXR agonist with potential for improved safety

June 8, 2018

Researchers unveil TMEM16A as potential therapeutic target for cystic fibrosis

June 8, 2018

Vonoprazan noninferior to lansoprazole in phase III erosive esophagitis study

June 8, 2018

MannKind announces completion of phase I study of TreT in pulmonary arterial hypertension

June 8, 2018

Biogen enters agreement to acquire stroke drug candidate from TMS

June 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...